TR200000172T2 - Mutasyona uğramış insan proteinlerinin insan hücrelerinde homolog tekrar birleşim ile üretilmesi. - Google Patents

Mutasyona uğramış insan proteinlerinin insan hücrelerinde homolog tekrar birleşim ile üretilmesi.

Info

Publication number
TR200000172T2
TR200000172T2 TR2000/00172T TR200000172T TR200000172T2 TR 200000172 T2 TR200000172 T2 TR 200000172T2 TR 2000/00172 T TR2000/00172 T TR 2000/00172T TR 200000172 T TR200000172 T TR 200000172T TR 200000172 T2 TR200000172 T2 TR 200000172T2
Authority
TR
Turkey
Prior art keywords
production
homologous recombination
human
mutated
human cells
Prior art date
Application number
TR2000/00172T
Other languages
English (en)
Turkish (tr)
Inventor
Stern Anne
Honold Konrad
Original Assignee
Roche Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8227102&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TR200000172(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Roche Diagnostics Gmbh filed Critical Roche Diagnostics Gmbh
Publication of TR200000172T2 publication Critical patent/TR200000172T2/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102Mutagenizing nucleic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90Stable introduction of foreign DNA into chromosome
    • C12N15/902Stable introduction of foreign DNA into chromosome using homologous recombination
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Mycology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
TR2000/00172T 1997-07-23 1998-07-22 Mutasyona uğramış insan proteinlerinin insan hücrelerinde homolog tekrar birleşim ile üretilmesi. TR200000172T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97112639 1997-07-23

Publications (1)

Publication Number Publication Date
TR200000172T2 true TR200000172T2 (tr) 2000-12-21

Family

ID=8227102

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/00172T TR200000172T2 (tr) 1997-07-23 1998-07-22 Mutasyona uğramış insan proteinlerinin insan hücrelerinde homolog tekrar birleşim ile üretilmesi.

Country Status (17)

Country Link
US (2) US6444441B1 (https=)
EP (1) EP1000167B2 (https=)
JP (1) JP2001511341A (https=)
KR (1) KR100512018B1 (https=)
CN (2) CN1265152A (https=)
AR (2) AR013251A1 (https=)
AT (1) ATE313643T1 (https=)
AU (1) AU729489B2 (https=)
BR (1) BR9811531A (https=)
CA (1) CA2297660C (https=)
DE (1) DE59813296D1 (https=)
DK (1) DK1000167T4 (https=)
ES (1) ES2255177T5 (https=)
PT (1) PT1000167E (https=)
TR (1) TR200000172T2 (https=)
WO (1) WO1999005264A2 (https=)
ZA (1) ZA986517B (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017118726A1 (en) * 2016-01-06 2017-07-13 Lonza Ltd Inhibition of protein degradation for improved production

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5234686A (en) * 1985-04-03 1993-08-10 Beecham Group P.L.C. Human tissue plasminogen activator consisting essentially of t-PA residues to 160 to 527, pharmaceutical compositions and methods of treatment
US5094953A (en) * 1988-03-21 1992-03-10 Genentech, Inc. Human tissue plasminogen activator variants
DE3903581A1 (de) * 1989-02-07 1990-08-16 Boehringer Mannheim Gmbh Gewebs-plasminogenaktivator-derivat
DE3907679A1 (de) * 1989-03-09 1990-09-13 Max Planck Gesellschaft Verfahren zur gezielten veraenderung eines gens
JPH0576361A (ja) * 1990-05-10 1993-03-30 Takeda Chem Ind Ltd 組織プラスミノーゲンアクチベータームテイン
DE69133557D1 (de) * 1990-08-29 2007-03-15 Pharming Intellectual Pty Bv Homologe rekombination in säugetier-zellen
AU664847B2 (en) 1991-05-15 1995-12-07 Cell Genesys, Inc. Genomic modifications with homologous DNA targeting
US6270989B1 (en) * 1991-11-05 2001-08-07 Transkaryotic Therapies, Inc. Protein production and delivery
US5641670A (en) * 1991-11-05 1997-06-24 Transkaryotic Therapies, Inc. Protein production and protein delivery
AU4115693A (en) * 1992-04-24 1993-11-29 Sri International In vivo homologous sequence targeting in eukaryotic cells
AU5087193A (en) * 1992-08-21 1994-03-15 Regents Of The University Of California, The Composition and method for altering dna sequences by homologous recombination
TW402639B (en) * 1992-12-03 2000-08-21 Transkaryotic Therapies Inc Protein production and protein delivery
CN1256986C (zh) * 1993-12-02 2006-05-24 转移染色体治疗公司 蛋白质的生产和蛋白质的输送
WO1996040271A1 (en) * 1995-06-07 1996-12-19 Yale University Treatment of hemoglobinopathies
US6087129A (en) * 1996-01-19 2000-07-11 Betagene, Inc. Recombinant expression of proteins from secretory cell lines

Also Published As

Publication number Publication date
ES2255177T3 (es) 2006-06-16
EP1000167B2 (de) 2011-04-20
US20020068318A1 (en) 2002-06-06
ATE313643T1 (de) 2006-01-15
AU9067398A (en) 1999-02-16
DK1000167T3 (da) 2006-04-24
EP1000167A2 (de) 2000-05-17
AU729489B2 (en) 2001-02-01
BR9811531A (pt) 2000-08-22
KR100512018B1 (ko) 2005-09-02
ES2255177T5 (es) 2011-07-12
KR20010022127A (ko) 2001-03-15
ZA986517B (en) 2000-01-24
JP2001511341A (ja) 2001-08-14
DE59813296D1 (de) 2006-01-26
PT1000167E (pt) 2006-05-31
CN1265152A (zh) 2000-08-30
CN101348789B (zh) 2016-08-17
CA2297660C (en) 2010-04-27
CA2297660A1 (en) 1999-02-04
US6444441B1 (en) 2002-09-03
WO1999005264A2 (de) 1999-02-04
AR068104A2 (es) 2009-11-04
CN101348789A (zh) 2009-01-21
US20020177195A1 (en) 2002-11-28
WO1999005264A3 (de) 1999-04-22
AR013251A1 (es) 2000-12-13
DK1000167T4 (da) 2011-08-08
EP1000167B1 (de) 2005-12-21

Similar Documents

Publication Publication Date Title
DE3855523D1 (de) Proteine mit Faktor-VIII-Aktivität, Verfahren zu deren Herstellung unter Verwendung von genetisch modifizierten Zellen und diese enthaltende pharmazeutische Zusammensetzungen
DE69939327D1 (de) Funktionelle antagonisten von hedgehog-aktivität
HUP9802212A2 (hu) Humán terápiában alkalmazható rekombináns anti-CD4-ellenanyagok
DE68918867D1 (de) Mutanten des hiv-1 Hüllproteins mit fehlenden hypervariabelen domänen.
HUP0000302A2 (hu) OB fúziós protein készítmények és módszerek
TR199901971T2 (xx) Bir resept�re ba�lanan peptidler ve bile�ikler.
HUP9801433A2 (hu) IIb/IIIa Glikoprotein antagonisták, ezek előállítása és alkalmazása, valamint ezeket tartalmazó gyógyászati készítmények
ATE182628T1 (de) Ein protein, das spezifische dna-strukturen erkennt, und seine verwendungen
MX9702666A (es) Nuevos peptidos con efectos inmunoreguladores.
HUP9700826A1 (hu) Peptikus fekély elleni gyógyászati készítmények
TR200000140T2 (tr) Endojenik gen etkinliği ile insan proteini üretimi için insan hücre sıralarının belirlenmesi
TR199700261A2 (xx) Yeni Pirimido (1,2-a) indoller.
TR200000172T2 (tr) Mutasyona uğramış insan proteinlerinin insan hücrelerinde homolog tekrar birleşim ile üretilmesi.
PT948319E (pt) Celulas encapsuladas produtoras de anticorpos
IL124939A0 (en) Vector for expression of n-terminally extended proteins in yeast cell
PT977859E (pt) O factor neurotrofico nnt-1
ATE260339T1 (de) Antikörper gegen menschliches restrictin
NO870398L (no) Fremgangsmaate for fremstilling av terapeutisk aktive organiske platinakomplekser.
ATE334207T1 (de) Zellzikluskontrollpunkt-spezifische gene
NO874391L (no) Nye gjaerekspresjonsvektorer for ifn-omega samt fremgangsmaate for fremstilling og anvendelse derav.
UA34210A (uk) Спосіб визначення патогенезу шлуночкових аритмій серця в експерименті
AR242636A1 (es) Gen con codificacion para actividad de factor estimulante de colonias de granulocitos humanos.